Evogene Ltd (NASDAQ: EVGN) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT EVOGENE LTD

Evogene Ltd (NASDAQ: EVGN)
Listen to this Section


$1.46
-0.0110 ( -2.73% ) 12.9K

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.

Market Data


Open $1.46
Previous Close $1.47
Volume 12.9K
Market Cap $9.58M
Day Range $1.43 - $1.52
52 Week Range $1.20 - $10.40
Shares Outstanding 6.51M
Change % -2.73%
Net Change ▼ -0.0110
Insider Ownership N/A
Exchange NASDAQ
Sector Industrials
Industry Agricultural Chemicals
IPO Year 2013
Country Israel
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Form 6-K 4 Mar 28, 2024
20-f Annual reports 122 Mar 28, 2024
effect Other 1 Mar 28, 2024
424b5 Other 3 Mar 28, 2024
corresp Comment letters 1 Mar 26, 2024
6-k Form 6-K 3 Mar 20, 2024
upload Comment letters 2 Mar 13, 2024
6-k Form 6-K 3 Mar 07, 2024
f-3 Other 11 Mar 01, 2024
6-k Form 6-K 4 Feb 22, 2024

Latest News


× Before browsing our site, please accept our cookies policy